Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth | |
Huang, Jie; Hu, Wei; Hu, Limin; Previs, Rebecca A.; Dalton, Heather J.; Yang, Xiao-Yun; Sun, Yunjie; McGuire, Michael; Rupaimoole, Rajesha; Nagaraja, Archana S. | |
刊名 | MOLECULAR CANCER THERAPEUTICS |
2016 | |
卷号 | 15期号:6 |
ISSN号 | 1535-7163 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4642208 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Huang, Jie,Hu, Wei,Hu, Limin,et al. Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth[J]. MOLECULAR CANCER THERAPEUTICS,2016,15(6). |
APA | Huang, Jie.,Hu, Wei.,Hu, Limin.,Previs, Rebecca A..,Dalton, Heather J..,...&Sood, Anil K..(2016).Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.MOLECULAR CANCER THERAPEUTICS,15(6). |
MLA | Huang, Jie,et al."Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth".MOLECULAR CANCER THERAPEUTICS 15.6(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论